1. Home
  2. CACI vs LEGN Comparison

CACI vs LEGN Comparison

Compare CACI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$541.97

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.59

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
LEGN
Founded
1962
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
5.9B
IPO Year
1979
2020

Fundamental Metrics

Financial Performance
Metric
CACI
LEGN
Price
$541.97
$22.59
Analyst Decision
Buy
Strong Buy
Analyst Count
14
13
Target Price
$616.50
$69.58
AVG Volume (30 Days)
256.3K
2.3M
Earning Date
01-21-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
12.06
N/A
EPS
22.62
N/A
Revenue
$8,858,558,000.00
$909,045,000.00
Revenue This Year
$10.72
$68.52
Revenue Next Year
$6.19
$48.63
P/E Ratio
$23.96
N/A
Revenue Growth
12.61
74.75
52 Week Low
$318.60
$21.19
52 Week High
$632.77
$45.30

Technical Indicators

Market Signals
Indicator
CACI
LEGN
Relative Strength Index (RSI) 32.41 33.52
Support Level $538.10 $21.19
Resistance Level $563.00 $23.24
Average True Range (ATR) 12.90 1.04
MACD -5.46 0.18
Stochastic Oscillator 6.03 21.26

Price Performance

Historical Comparison
CACI
LEGN

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: